ABC | Volume 114, Nº5, Maio 2020

Artigo de Revisão Costa et al. O coração e a COVID-19 Arq Bras Cardiol. 2020; 114(5):805-816 1. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation. 2020 Mar 21. [Epub ahead of print]. 2. Ganatra S HS, Hammond SP, Nohria A. The novel coronavirus disease (COVID-19) threat for patients with cardiovascular disease and cancer. JACC CardioOncology. 2020 Mar. [Epub ahead of print]. 3. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020;25(10):2000180. 4. Driggin E, MadhavanMV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020 Mar 18;pii: S0735-1097(20)34637-4. 5. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207. 6. Li R, Pei S, Chen B, Song Y, Zhang T, YangW, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS- CoV2). Science. 2020 Mar 16;pii:eabb3221. [Epub ahead of print]. 7. Brasil.Ministério da Saúde. Secretaria de Vigilância em Saúde. Boletim Epidemiológico7–COECoronavírus–06deabrilde2020.Brasília(DF);2020. 8. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020 Feb 24. [Epub ahead of print]. 9. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020 Feb 7. [Epub ahead of print]. 10. GuoT,FanY,ChenM,WuX,ZhangL,HeT,etal.Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 11. Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020 Mar 25. [Epub ahead of print]. 12. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. 13. Xiong TY, Redwood S, Prendergast B, Chen M. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 Mar 18;pii:ehaa231. [Epub ahead of print]. 14. Hu H, Ma F, Wei X, Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. 2020 Mar 16;pii:ehaa190. [Epub ahead of print]. 15. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020 Mar 5. [Epub ahead of print]. 16. Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020 Mar 10;pii:S0033-0620(20)30055-4. [Epub ahead of print]. 17. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. 18. Chen C, Zhou Y, Wang DW. SARS-CoV-2: a potential novel etiology of fulminant myocarditis. Herz. 2020 Mar 5. [Epub ahead of print]. 19. Inciardi RM, Lupi L, Zaccone G, Italia L, RaffoM, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 20. da Silva Costa IBS, Figueiredo CS, Fonseca SMR, Bittar CS, de Carvalho Silva CMD, Rizk SI, et al. Takotsubo syndrome: an overview of pathophysiology, diagnosis and treatment with emphasis on cancer patients. Heart Fail Rev. 2019;24(6):833-46. 21. Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020 Mar 27. [Epub ahead of print]. 22. Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike proteinforriskofhumantransmission.SciChinaLifeSci.2020;63(3):457-60. 23. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. 24. Liu Z, Xiao X, Wei X, Li J, Yang J, Tan H, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol. 2020 Feb 26. [Epub ahead of print]. 25. Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin-Aldosterone System inhibitors in patients with Covid-19. N Engl J Med. 2020Mar 30. [Epub ahead of print]. 26. Rice GI, Thomas DA, Grant PJ, Turner AJ, Hooper NM. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J. 2004;383(Pt 1):45-51. 27. SociedadeBrasileiradeCardiologia.SBC Informa. InfecçãopeloCoronavírus 2019(COVID-19);2020.[Citado18mar.2020].Disponívelem:http://www. cardiol.br/sbcinforma/2020/20200315-comunicado-coronavirus.html. 28. American College of Cardiology. ACC Clinical Bulletin COVID-19 Clinical Guidance For the Cardiovascular Care Team; 2020. 29. Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020 Feb 19. [Epub ahead of print]. 30. Wang Z, Yang B, Li Q, Wen L, Zhang R. Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China. Clin Infect Dis. 2020 Mar 16;pii:ciaa272. [Epub ahead of print]. 31. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. 32. GuanWJ, Ni ZY, Hu Y, LiangWH, OuCQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020 Feb 28. [Epub ahead of print]. 33. Chinese Center for Disease Control and Prevention. The epidemiological characteristicsofanoutbreakof2019novelcoronavirusdiseases(COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(2):145-51. 34. Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good orbadnewsfromthe2018GlobalCancerStatistics?CancerCommun(Lond). 2019;39(1):22. 35. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. 36. AmericanCollegeofCardiology.CardiologyMagazine.Ventriculararrhythmia risk due to hydroxychloroquine-azithromycin treatment for COVID-19; 2020. [Cited in 2020Mar 20] Available from: https://www.acc.org/latest-in- cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to- hydroxychloroquine-azithromycin-treatment-for-covid-19) 37. Yang F, Wang J, Li W, Xu Y, Wan K, Zeng R, et al. The prognostic value of late gadolinium enhancement in myocarditis and clinically suspected myocarditis: systematic review and meta-analysis. Eur Radiol. 2020 Feb 10. [Epub ahead of print]. Referências 815